Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger S Lo

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Cancer Discovery|December 15, 2020
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell ImmunityAayoung Hong, Marco Piva, Sixue Liu, et al.
Cancer Discovery|July 1, 2024
Expression of Concern: Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell ImmunityAayoung Hong, Marco Piva, Sixue Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsDouglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Phylogenetic analyses of melanoma reveal complex patterns of metastatic disseminationJ Zachary Sanborn, Jongsuk Chung, Elizabeth Purdom, et al.
Nature Medicine|April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Genetics|October 17, 2022
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCHKing L Hung, Jens Luebeck, Siavash R Dehkordi, et al.
Nature Medicine|January 30, 2021
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Cancer Discovery|December 15, 2020
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell ImmunityAayoung Hong, Marco Piva, Sixue Liu, et al.
Cancer Discovery|July 1, 2024
Expression of Concern: Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell ImmunityAayoung Hong, Marco Piva, Sixue Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsDouglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Phylogenetic analyses of melanoma reveal complex patterns of metastatic disseminationJ Zachary Sanborn, Jongsuk Chung, Elizabeth Purdom, et al.
Nature Medicine|April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Genetics|October 17, 2022
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCHKing L Hung, Jens Luebeck, Siavash R Dehkordi, et al.
Nature Medicine|January 30, 2021
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Pageof 9